Corrigendum to "The role of cannabinoid ligands in neurodegenerative diseases: Emerging anti-inflammatory, immunomodulation and disease-modifying perspectives" [Pharmacol. Res. 227 (2026) 108185].
- DOI
- 10.1016/j.phrs.2026.108206
- Published
- 2026-04-23
- Container
- Pharmacol Res
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.phrs.2026.108206,
title = {Corrigendum to "The role of cannabinoid ligands in neurodegenerative diseases: Emerging anti-inflammatory, immunomodulation and disease-modifying perspectives" [Pharmacol. Res. 227 (2026) 108185].},
author = {Baldasso GM and Paes RS and Moreira AG and Salvadori SG and Limberger C and Roviezzo F and Capasso R and Dutra RC.},
year = {2026},
journal = {Pharmacol Res},
doi = {10.1016/j.phrs.2026.108206},
url = {https://doi.org/10.1016/j.phrs.2026.108206}
}RIS
TY - JOUR TI - Corrigendum to "The role of cannabinoid ligands in neurodegenerative diseases: Emerging anti-inflammatory, immunomodulation and disease-modifying perspectives" [Pharmacol. Res. 227 (2026) 108185]. AU - Baldasso GM AU - Paes RS AU - Moreira AG AU - Salvadori SG AU - Limberger C AU - Roviezzo F AU - Capasso R AU - Dutra RC. PY - 2026 JO - Pharmacol Res DO - 10.1016/j.phrs.2026.108206 UR - https://doi.org/10.1016/j.phrs.2026.108206 ER -
APA
GM, B., RS, P., AG, M., SG, S., C, L., F, R., R, C., & RC., D. (2026). Corrigendum to "The role of cannabinoid ligands in neurodegenerative diseases: Emerging anti-inflammatory, immunomodulation and disease-modifying perspectives" [Pharmacol. Res. 227 (2026) 108185].. Pharmacol Res. https://doi.org/10.1016/j.phrs.2026.108206
Source records
- europe-pmc · retrieved 2026-09-26T11:00:56.576Z